MedTrace Logo

Efficacy of Platelet-rich Plasma in Improving Postoperative Scarring After Cesarean Delivery

NCT06978010 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-05-21

No results posted yet for this study

Summary

Cesarean section often leads to postoperative scarring, which can impact both physical and psychological well-being. Platelet-rich plasma (PRP), rich in growth factors, is used in regenerative medicine to promote healing and reduce inflammation.

Conditions

  • Cesarean Section Wound
  • Platelet-rich Plasma (PRP)
  • Regenerative Medicine

Interventions

OTHER

Platelet-Rich Plasma (PRP) intraoperatively

Patients receive platelet-rich plasma (PRP) intraoperatively during cesarean section (5 ml before hysterography, 5 ml subcutaneously before skin closure).

Sponsors & Collaborators

  • Saint Andrew Hospital Constanta

    lead OTHER

Principal Investigators

  • Vlad Iustin Tica, Proffesor · Ovidius University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2024-01-31
Completion
2024-01-31

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06978010 on ClinicalTrials.gov